Drug Toxicity

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Holiday Hazard Tips from The Drug and Poison Information Center

Published December 2, 2008, 10:24 am, Newswise

The holiday season is usually a time of joy but it also brings the potential for poisonings, according to the Drug and Poison Information Center (DPIC), a service of Cincinnati Children's Hospital Medical Center. The following information includes safety hazards and precautionary ways to ensure that families have a safe holiday season.

Discover News | Full Story


NanoVector To Commercialize First Biologic Nanoparticle Drug Delivery System

Published December 2, 2008, 9:13 am, PharmaceuticalOnline

NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors' Stefan Franzen and Steven Lommel from North Carolina State University.

Discover News | Full Story


Research and Markets: A Pathway Analysis for Drug Discovery: Save Time and Money in the Drug Discovery Process by ...

Published December 2, 2008, 8:32 am, Centre Daily Times

Research and Markets ( http://www.researchandmarkets.com/research/247552/pathway_analysis_f ) has announced the addition of John Wiley and Sons Ltd's new report " Pathway Analysis for Drug Discovery: Computational Infrastructure and Applications " to their offering.

Discover News | Full Story


Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints

Published December 2, 2008, 8:27 am, EurekAlert!

( WeissComm Partners ) Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the ...

Discover News | Full Story


Research and Markets: A Pathway Analysis for Drug Discovery: Save Time and Money in the Drug Discovery Process by ...

Published December 2, 2008, 8:00 am, Business Wire via Yahoo! Finance

DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Pathway Analysis for Drug Discovery: Computational Infrastructure and Applications" to their offering.

Discover News | Full Story


Learn about the US Biochips Market

Published December 2, 2008, 6:42 am, Business Wire via Yahoo! Finance

NEW YORK----Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.

Discover News | Full Story


YOU ARE HERE:

Published December 2, 2008, 5:45 am, Aidsmap

Two cases of liver toxicity caused by the anti-HIV drug abacavir ( Ziagen , also in the combination pill Kivexa ) have been reported in the November 30 th edition of AIDS . Both cases involved young women who changed their HIV treatment to include abacavir.

Discover News | Full Story


NanoVector to Commercialize First Biologic Nanoparticle Drug Delivery System

Published December 2, 2008, 5:32 am, Centre Daily Times

NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors’ Stefan Franzen and Steven Lommel from North Carolina State University. “This is breakaway technology that will finally provide the highly sought after selective targeting of tumors and intracellular delivery of anti-cancer agents for improved efficacy and fewer ...

Discover News | Full Story


Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

Published December 2, 2008, 5:30 am, PR Newswire via Yahoo! Finance

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.

Discover News | Full Story


Immunomedics to Present At 50th ASH Annual Meeting

Published December 2, 2008, 5:30 am, GlobeNewswire via Yahoo! Finance

MORRIS PLAINS, N.J., Dec. 2, 2008 -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that seven presentations involving its potential products will be given at the 50th American Society of Hematology Annual Meeting, scheduled for December 6 - 9, 2008, in San Francisco, California.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a